barrier
compris
capillari
endothelium
alveolar
epithelium
pulmonari
alveoli
primari
site
ga
exchang
blood
compos
thin
alveolar
epithelium
cover
airspac
surfac
area
lung
contain
thin
squamou
type
cell
cuboid
type
ii
type
cell
cover
alveolar
surfac
also
apposit
alveolar
epithelium
vascular
endothelium
area
facilit
effici
ga
exchang
form
tight
barrier
fluid
protein
movement
interstiti
vascular
space
therebi
maintain
rel
dri
alveoli
tight
junction
connect
adjac
epitheli
cell
near
apic
surfac
maintain
apic
basolater
cell
polar
junction
critic
element
permeabl
barrier
requir
maintain
discret
compart
alveolar
type
ii
cell
known
surfact
secret
thought
contribut
vectori
transport
activ
transport
sodium
provid
major
drive
forc
fluid
remov
alveolar
space
amiloridesensit
sodium
channel
apic
surfac
mainli
epitheli
sodium
channel
enac
involv
fluid
transport
drive
forc
repres
nakatpas
basolater
besid
pulmonari
epithelia
endotheli
barrier
function
also
key
compon
mainten
integr
vascular
boundari
lung
particularli
sinc
ga
exchang
surfac
area
alveolarcapillari
membran
endotheli
cell
line
pulmonari
vasculatur
form
semiperm
barrier
blood
interstitium
lung
disrupt
barrier
occur
inflammatori
diseas
state
pneumonia
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
barrier
dysfunct
result
movement
fluid
macromolecul
interstitium
pulmonari
air
space
process
significantli
contribut
high
morbid
mortal
patient
afflict
acut
lung
although
mani
diseas
caus
pulmonari
edema
mean
one
combin
follow
three
process
increas
capillari
pressur
lung
increas
permeabl
disrupt
alveolarepithelialendotheli
barrier
permeabl
edema
dysregul
express
function
crucial
ion
channel
type
ii
alveolar
epitheli
cell
type
ii
aec
implic
lung
liquid
clearanc
apic
express
epitheli
sodium
channel
enac
basolater
express
nakatpas
consequ
reduct
lung
complianc
impair
ga
exchang
may
occur
lead
hypoxemia
respiratori
acidosi
patient
pulmonari
edema
show
typic
symptom
includ
short
breath
lungcrackl
sound
pinkstain
sputum
cough
anxieti
breath
difficulti
restless
wheez
cardiogen
pulmonari
edema
defin
pulmonari
edema
due
increas
capillari
hydrostat
pressur
secondari
elev
pulmonari
venou
also
call
hydrostat
edema
hemodynam
case
cardiogen
edema
causal
therapi
underli
diseas
often
preced
symptomat
treatment
impair
ga
exchang
eg
mean
noninvas
ventil
parallel
effici
medic
intervent
noncardiogen
pulmonari
edema
occur
due
chang
permeabl
pulmonari
capillari
alveolar
epitheli
membran
result
either
direct
indirect
patholog
process
therefor
also
known
permeabl
pulmonari
repres
spectrum
ill
rang
less
sever
form
ali
ard
mainstay
treatment
mechan
ventil
maxim
ventil
oxygen
judici
use
posit
endexpiratori
pressur
peep
newer
ventil
techniqu
highfrequ
oscillatori
ventil
partial
fluid
ventil
promis
still
earli
stage
clinic
test
mortal
rate
unfortun
remain
high
despit
increas
therapi
develop
intens
care
indic
clinic
hydrostat
edema
mostli
consequ
heart
failur
wherea
noncardiogen
pulmonari
edema
mostli
consequ
acut
lung
inflamm
ard
medic
emerg
character
sudden
failur
respiratori
system
nhlbi
estim
approxim
american
affect
ard
approxim
ard
case
fatal
mortal
rate
even
patient
age
year
accumul
evid
capac
lung
clear
edema
liquid
essenti
outcom
cardiogen
noncardiogen
pulmonari
edema
patient
ard
dramat
reduc
life
expect
fluid
reabsorpt
capac
apart
strategi
optim
ventil
procedur
current
standard
therapi
exist
permeabl
edema
moreov
viral
bacteri
infect
induc
chang
express
function
epitheli
sodium
channel
enac
therefor
search
substanc
abl
reduc
endotheli
hyperperm
andor
restor
sodium
uptak
type
ii
aec
import
surfac
express
enac
mainli
regul
via
neural
precursor
cellexpress
development
downregul
gene
protein
lead
ubiquitinyl
subsequ
degrad
sodium
channel
specif
kinas
cell
volum
stressactiv
serum
glucocorticoid
depend
kinas
protein
kinas
b
part
insulin
insulinlik
growth
factor
signal
pathway
recent
propos
control
surfac
express
enac
mean
phosphoryl
subsequ
reduc
bind
altern
shown
phosphoryl
ino
type
ii
alveolar
epitheli
cell
reduc
product
inhibit
na
also
counteract
protein
kinas
c
pkc
activ
pkc
import
neg
regul
enac
express
recent
pkc
alpha
zeta
isozym
found
crucial
enac
downregul
caus
protein
influenza
recent
also
oxid
stress
often
occur
lung
condit
infect
inflamm
demonstr
interfer
enac
express
inde
lung
epitheli
cell
line
cell
oxid
stress
shown
reduc
express
alpha
subunit
regard
interest
note
main
etiolog
agent
commun
acquir
pneumonia
ie
streptococcu
pneumonia
lack
catalas
therefor
secret
virul
within
endotheli
cell
three
primari
signal
pathway
initi
bind
vasoact
factor
leukocyt
adhes
rho
gtpase
reactiv
oxygen
speci
ro
tyrosin
phosphoryl
junction
protein
pathway
converg
regul
junction
permeabl
either
affect
stabil
junction
protein
modul
interact
regul
junction
permeabl
mediat
dynam
interact
protein
adheren
junction
repres
tight
junction
endotheli
cell
actin
actinmyosindriven
contract
gener
contractil
forc
pull
vecadherin
inward
thu
forc
dissoci
adjac
partner
produc
interendotheli
gap
anoth
possibl
mechan
adheren
junction
disassembl
interendotheli
gap
format
involv
microtubul
disassembl
rise
cytosol
propos
initi
pivot
signal
preced
endotheli
cell
contract
sinc
activ
key
signal
pathway
mediat
cytoskelet
reorgan
myosin
light
chain
mlc
depend
contract
disassembl
vecadherin
adheren
junction
rho
ra
homolog
gtpbind
protein
compris
multipl
member
rho
rac
subfamili
involv
regul
varieti
cellular
rhoa
play
import
role
regul
cytoskelet
remodel
ec
barrier
rhoa
rhoassoci
kinas
may
directli
catalyz
mlc
phosphoryl
act
indirectli
via
inactiv
mlc
induc
cell
contract
endotheli
barrier
disrupt
turn
endotheli
barrier
enhanc
associ
rac
format
factin
increas
associ
focal
adhes
protein
enlarg
intercellular
adheren
thu
precis
balanc
rhoa
signal
essenti
endotheli
barrier
regul
pkc
isoform
suggest
play
critic
role
initi
endotheli
cell
contract
disassembl
vecadherin
nadph
oxidas
major
sourc
ro
endotheli
cell
implic
redoxsensit
signal
pathway
influenc
endotheli
cytoskelet
organ
apart
induc
rhoa
activ
also
recent
shown
upregul
nox
mrna
express
human
endotheli
death
sever
bacteri
pneumonia
occur
day
initi
antibiot
therapi
tissu
steril
pneumonia
clear
correl
presenc
bacteri
grow
evid
aspect
immun
respons
greatli
contribut
high
mortal
rate
immunosuppress
patient
die
consequ
poor
host
respons
immunocompet
host
face
overwhelm
inflammatori
reaction
contribut
tissu
injuri
shock
death
view
crucial
role
bacteri
virul
profound
effect
immun
system
host
poreform
toxin
pneumolysin
pli
pneumonia
homolog
toxin
listeriolysin
llo
listeria
monocytogen
consid
model
toxin
g
infectionassoci
acut
lung
injuri
permeabl
edema
toxin
bind
cholesterol
follow
oligomer
membran
pore
format
result
rapid
increas
intracellular
diacylglycerol
sever
pulmonari
interact
streptococcu
pneumonia
endotheli
cell
repres
crucial
step
pathogenesi
intravascular
pli
shown
caus
signific
dosedepend
increas
pulmonari
vascular
resist
lung
microvascular
permeabl
immunohistochemistri
pli
could
detect
mainli
endotheli
cell
pulmonari
arteri
vessel
concomitantli
display
strong
vasoconstrict
toxin
moreov
increas
permeabl
huvec
could
recent
show
sublyt
concentr
llo
induc
cholesteroldepend
actin
remodel
mean
interf
activ
small
gtp
bind
protein
rhoa
pulmonari
human
microvascular
endotheli
known
inflamm
play
import
role
pathogenesi
pulmonari
edema
system
inflammatori
respons
trigger
circul
monocyt
alveolar
macrophag
neutrophil
secret
cytokin
chemokin
includ
tnf
substanti
evid
suggest
cytokin
import
mediat
lung
injuri
follow
infect
exposur
microbi
tnf
also
play
import
role
activ
host
defens
promot
product
wide
spectrum
cytokin
chemokin
granulocytemacrophag
coloni
stimul
factor
inflammatori
proinflammatori
cytokin
activ
leukocyt
endotheli
cell
cell
increas
express
surfac
adhes
molecul
neutrophil
leukocyt
platelet
adher
via
cognat
receptor
pulmonari
endothelium
activ
neutrophil
releas
proteas
leukotrien
reactiv
oxygen
intermedi
inflammatori
molecul
amplifi
inflammatori
respons
ro
proteas
directli
damag
membran
ro
also
implic
ischemiareperfus
damag
follow
lung
date
mani
studi
shown
tnf
contribut
pathogenesi
develop
pulmonari
upon
check
cytotox
effect
pulmonari
endothelium
bronchoalveolar
lavag
fluid
balf
differ
group
patient
found
significantli
higher
tnf
level
balf
patient
earlystag
ard
compar
control
risk
latestag
ard
patient
indic
implic
cytokin
barrier
dysfunct
acut
phase
contrast
new
evid
emerg
suggest
tnf
stimul
lung
liquid
neutral
cytokin
neutral
antibodi
increas
accumul
edema
therefor
role
tnf
regul
alveolar
liquid
clearanc
activ
sodium
transport
still
controversi
other
group
tri
unravel
mechan
action
edema
format
tnf
potent
proinflammatori
cytokin
produc
mani
cell
type
includ
monocyt
macrophag
lymphocyt
endotheli
cell
tnf
found
serum
bacillu
calmetteguerin
bcg
infect
mice
got
name
dr
old
abil
mediat
endotoxininduc
hemorrhag
earli
group
fier
pennica
independ
clone
tnf
cdna
reveal
homolog
amino
acid
sequenc
lymphotoxin
lt
lymphokin
similar
biolog
similar
tnf
lt
sequenc
function
lead
renam
tnf
lt
meanwhil
nomenclatur
chang
tnf
kriegler
et
al
identifi
character
rapidli
induc
cell
surfac
cytotox
integr
transmembran
form
tnf
name
membran
black
et
al
found
membraneintegr
tnf
specif
releas
via
proteolyt
cleavag
metalloproteas
tnfalphaconvert
enzym
inactiv
code
gene
mous
cell
caus
mark
decreas
solubl
tnf
two
specif
receptor
interact
tnf
cell
surfac
tnf
receptor
type
tnf
receptor
type
express
tissu
fulli
activ
membranebound
solubl
trimer
form
tnf
wherea
found
cell
immun
system
respond
membranebound
form
tnf
share
structur
similar
extracellular
domain
two
tnfr
differ
intracellular
domain
signal
transduct
consequ
receptorligand
interact
caus
intracellular
signal
without
intern
complex
lead
phosphoryl
nfkb
activ
subunit
interact
dna
chromatin
structur
increas
transcript
proinflammatori
gene
although
gener
assum
cytokin
sole
exert
activ
upon
activ
respect
receptor
seem
complet
true
case
tnf
inde
contrast
lymphotoxinalpha
highli
homolog
structur
tnf
abl
bind
tnf
receptor
tnf
shown
exert
lytic
activ
purifi
long
slender
bloodstream
form
african
trypanosom
mean
lectinlik
interact
oligosaccharid
residu
surfac
investig
found
lectinlik
activ
attribut
special
domain
name
lectinlik
domain
spatial
distinct
receptor
bind
confirm
find
n
n
diacetylchitobios
specif
bind
oligosaccharid
lectinlik
domain
block
trypanolyt
effect
wherea
leav
cytotox
activ
tnf
cancer
cell
line
moreov
circular
seventeen
amino
acid
peptid
name
tip
peptid
deriv
tip
region
tnf
mimic
function
structur
lectinlik
domain
similar
lytic
effect
african
recent
year
evid
collect
demonstr
tnf
domain
distinct
two
classic
receptor
regard
locat
tnf
molecul
also
function
differ
physiopatholog
process
type
ii
alveolar
epitheli
cell
small
airway
epitheli
cell
repres
primari
site
reabsorpt
na
lung
na
ion
alveolar
line
fluid
shown
passiv
diffus
fetal
distal
lung
epitheli
alveolar
epitheli
type
ii
cell
nonselect
cation
channel
na
select
amiloridesensit
channel
import
epitheli
sodium
channel
enac
locat
apic
membran
consist
least
subunit
ie
alpha
beta
gamma
former
one
crucial
favor
electrochem
drive
forc
na
influx
maintain
basolater
express
ouabainsensit
na
katpas
transport
na
interstiti
epitheli
na
channel
repres
ratelimit
step
na
activ
na
transport
across
alveolar
epithelium
vivo
propos
help
reabsorpt
fetal
fluid
birth
keep
adult
alveolar
space
free
fluid
especi
alveolar
permeabl
plasma
protein
recent
data
studi
mice
reduc
enac
activ
also
clearli
illustr
impair
lung
fluid
clearanc
adult
inflammatori
process
lung
proinflammatori
substanc
tnf
produc
local
inde
demonstr
elev
tnf
level
balf
patient
dagenai
et
al
found
tnf
decreas
express
alpha
beta
gammasubunit
enac
mrna
control
hour
treatment
reduc
amount
alphaenac
protein
cell
impact
howev
nakatpas
mrna
express
moreov
studi
tnf
decreas
amiloridesensit
sodium
uptak
dosedepend
investig
potenti
role
tnf
enac
promot
activ
test
alveolar
epitheli
cell
result
show
tnf
decreas
luciferas
express
cell
indic
strong
diminut
enac
mrna
must
relat
posttranscript
recent
studi
suggest
least
kidney
inhibitori
effect
tnf
enac
express
occur
ceramidedepend
yamagata
et
al
report
direct
exposur
rat
alveolar
type
ii
cell
tnf
inhibit
mrna
express
alpha
gammaenac
betaenac
reduc
amiloridesensit
one
promin
featur
acut
lung
injuri
syndrom
disrupt
vascular
barrier
result
permeabl
pulmonari
edema
format
subsequ
respiratori
critic
import
pulmonari
vascular
barrier
function
shown
balanc
compet
endotheli
cell
contractil
forc
gener
centripet
tension
adhes
cellcel
cellmatrix
tether
forc
regul
cell
shape
compet
forc
model
intim
link
endotheli
cytoskeleton
complex
network
actin
microfila
microtubul
intermedi
filament
combin
regul
shape
chang
transduc
signal
within
endotheli
tnf
trigger
endotheli
cell
activ
barrier
dysfunct
implic
pathogenesi
pulmonari
goldblum
et
al
observ
human
recombin
tnf
could
provok
acut
pulmonari
vascular
endotheli
injuri
increas
pulmonari
vascular
permeabl
vivo
well
anoth
studi
tnf
shown
increas
permeabl
endotheli
cell
monolay
macromolecul
lower
molecular
weight
solut
mechan
involv
pertussi
toxinsensit
regulatori
g
wheatley
studi
also
show
tnf
could
increas
permeabl
lung
endotheli
cell
monolay
fibronectin
could
blunt
partridg
reveal
tnfinduc
increas
endotheli
permeabl
involv
loss
fibronectin
remodel
extracellular
also
shown
tnf
increas
capillari
permeabl
caus
transcapillari
filtrat
recent
studi
demonstr
tnf
caus
microtubul
rearrang
monolay
human
pulmonari
arteri
endotheli
besid
direct
deleteri
effect
na
channel
barrier
dysfunct
also
report
tnf
induc
pulmonari
edema
mean
augment
reactiv
oxygen
shown
abl
disrupt
pulmonari
endotheli
decreas
na
channel
intriguingli
mani
studi
alreadi
shown
tnf
contribut
format
pulmonari
edema
research
found
proinflammatori
cytokin
actual
increas
clearanc
alveolar
liquid
mainli
infect
model
rezaiguia
et
al
reveal
instil
tnf
rat
infect
pseudomona
aeruginosa
increas
alveolar
liquid
clearanc
h
compar
control
rat
moreov
antitnf
neutral
antibodi
instil
lung
min
bacteria
alveolar
liquid
clearanc
significantli
result
borjesson
studi
suggest
intestin
ischemiareperfus
rat
model
lead
stimul
alveolar
liquid
clearanc
stimul
mediat
least
part
tnfdepend
mechan
independ
catecholamin
releas
propranolol
effect
stimul
triplemut
murin
tnf
gener
upon
replac
crucial
residu
alanin
lectinlik
domain
tnf
trimer
tnf
lost
lectinlik
affin
essenti
retain
tnf
receptor
activ
display
reduc
tnf
receptor
bioactiv
subsequ
demonstr
tnf
increas
sodium
uptak
amiloridesensit
campindepend
mechan
cell
mean
lectinlik
shown
hribar
et
al
tnf
caus
phdepend
increas
sodium
current
primari
lung
microvascular
endotheli
cell
periton
macrophag
tnf
receptorindepend
amiloridedepend
manner
sinc
also
occur
cell
isol
mice
defici
tnf
receptor
type
studi
tip
peptid
also
increas
sodium
current
isol
endoexotoxintr
perfus
rabbit
lung
vadasz
et
al
recent
demonstr
tnfderiv
tip
peptid
significantli
lower
vascular
permeabl
assess
capillari
filtrat
coeffici
fluorescein
isothiocyanatelabel
albumin
flux
across
alveolocapillari
infect
g
bacterium
listeria
monocytogen
caus
sever
lung
complic
result
permeabl
edema
character
extens
capillari
endotheli
hyperperm
requir
harsh
therapeut
measur
often
fatal
llo
main
virul
factor
listeria
monocytogen
induc
dosedepend
hyperperm
monolay
human
lung
microvascular
endotheli
cell
vitro
recent
studi
tnfderiv
tip
peptid
mimic
lectinlik
domain
cytokin
shown
blunt
lloinduc
hyperperm
vitro
upon
inhibit
lloinduc
activ
ro
gener
mlc
phosphoryl
upon
restor
rhoarac
balanc
result
indic
lectinlik
domain
tnf
potenti
therapeut
valu
protect
lloinduc
pulmonari
endotheli
recent
studi
could
demonstr
tip
peptid
mimic
lectinlik
domain
tnf
abl
blunt
ro
product
pulmonari
arteri
endotheli
cell
hypoxia
reoxygen
reduc
ro
content
transplant
rat
lung
vivo
wherea
inact
mutant
tip
peptid
effect
use
uss
chamber
experi
primari
type
ii
rat
pneumocyt
conclud
primari
site
action
peptid
apic
side
cell
sinc
apic
basolater
stimul
monolay
tip
peptid
result
increas
amiloridesensit
transepitheli
activ
na
transport
across
alveolar
epithelium
regul
via
apic
express
na
chlorid
channel
also
mean
basolater
express
nakatpas
normal
injur
studi
vadasz
et
al
found
tip
peptid
increas
nakatpas
activ
promot
exocytosi
alveolar
epitheli
cell
surfac
increas
amiloridesensit
sodium
uptak
result
increas
activ
na
transport
henc
improv
clearanc
excess
fluid
alveolar
uss
chamber
result
would
rather
indic
indirect
role
nakatpas
effect
upon
previou
stimul
enac
pulmonari
edema
still
one
common
medic
emerg
standard
therapi
avail
permeabilityinduc
form
patholog
import
cytokin
involv
pathogenesi
tnf
exampl
moonlight
protein
differenti
activ
mediat
receptorbind
versu
lectinlik
domain
open
possibl
design
develop
sophist
therapeut
regimen
overcom
deleteri
fluid
accumul
major
lung
opinion
studi
mention
gener
import
advanc
understand
complex
tnf
effect
pulmonari
edema
howev
futur
research
need
order
reveal
underli
mechan
tnf
protect
versu
deleteri
effect
research
potenti
make
lectinlik
domain
tnf
attract
therapeut
option
patient
pulmonari
permeabl
edema
